Matthew Joseph Wieduwilt
Observed names: M. J. Wieduwilt, M. Wieduwilt, M.J. Wieduwilt, Matthew J Wieduwilt, Matthew J. Wieduwilt, Matthew Wieduwilt
Observed institutions: Atrium Health Wake Forest Baptist, Merck & Co., Inc., Rahway, NJ, USA (United States), Mayo Clinic, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Howard Hughes Medical Institute, Oregon Health & Science University, University of California, San Francisco, Medical College of Wisconsin, Washington University in St. Louis, Cornell University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Middlemore Hospital, Moffitt Cancer Center, University of California San Diego, Blueprint Medicines (United States), Jazz Pharmaceuticals (United States), University of Wisconsin Carbone Cancer Center, Dana-Farber Cancer Institute, University Hospitals Seidman Cancer Center, University of Kansas Medical Center, University of California San Diego Medical Center, Actinium Pharmaceuticals (United States), Gilead Sciences (United States), Astellas Pharma (United States), UCSF Helen Diller Family Comprehensive Cancer Center, Wake Forest Baptist Comprehensive Cancer Center, Moores Cancer Center, Case Comprehensive Cancer Center, OU Health Stephenson Cancer Center, Foundation Medicine (United States), Kite Pharma (United States), Wake Forest University Health Sciences, Wake Forest University, University of Oklahoma Health Sciences Center, The Ohio State University, University of Pennsylvania, University of California, Davis, The University of Texas Southwestern Medical Center, University of Oklahoma
ORCID: 0000-0002-5414-9228
Observed ORCID: 0000-0002-5414-9228
OpenAlex ID: A5007647176